BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 18988904)

  • 1. The emerging role of microRNAs in cardiac remodeling and heart failure.
    Divakaran V; Mann DL
    Circ Res; 2008 Nov; 103(10):1072-83. PubMed ID: 18988904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of microRNAs in cardiac remodeling and heart failure.
    Topkara VK; Mann DL
    Cardiovasc Drugs Ther; 2011 Apr; 25(2):171-82. PubMed ID: 21431305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical applications of miRNAs in cardiac remodeling and heart failure.
    Topkara VK; Mann DL
    Per Med; 2010 Sep; 7(5):531-548. PubMed ID: 21399714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-coding RNAs in cardiac remodeling and heart failure.
    Kumarswamy R; Thum T
    Circ Res; 2013 Aug; 113(6):676-89. PubMed ID: 23989712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNAs, heart failure, and aging: potential interactions with skeletal muscle.
    Murach KA; McCarthy JJ
    Heart Fail Rev; 2017 Mar; 22(2):209-218. PubMed ID: 27384434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating microRNA changes in heart failure patients treated with cardiac resynchronization therapy: responders vs. non-responders.
    Marfella R; Di Filippo C; Potenza N; Sardu C; Rizzo MR; Siniscalchi M; Musacchio E; Barbieri M; Mauro C; Mosca N; Solimene F; Mottola MT; Russo A; Rossi F; Paolisso G; D'Amico M
    Eur J Heart Fail; 2013 Nov; 15(11):1277-88. PubMed ID: 23736534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNAs in the development of left ventricular remodeling and postmyocardial infarction heart failure.
    Sygitowicz G; Maciejak-Jastrzębska A; Sitkiewicz D
    Pol Arch Intern Med; 2020 Jan; 130(1):59-65. PubMed ID: 31933487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-133 and miR-30 regulate connective tissue growth factor: implications for a role of microRNAs in myocardial matrix remodeling.
    Duisters RF; Tijsen AJ; Schroen B; Leenders JJ; Lentink V; van der Made I; Herias V; van Leeuwen RE; Schellings MW; Barenbrug P; Maessen JG; Heymans S; Pinto YM; Creemers EE
    Circ Res; 2009 Jan; 104(2):170-8, 6p following 178. PubMed ID: 19096030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of cardiac microRNAs induced by aerobic exercise training during heart failure.
    Souza RW; Fernandez GJ; Cunha JP; Piedade WP; Soares LC; Souza PA; de Campos DH; Okoshi K; Cicogna AC; Dal-Pai-Silva M; Carvalho RF
    Am J Physiol Heart Circ Physiol; 2015 Nov; 309(10):H1629-41. PubMed ID: 26408546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNAs in cardiac remodeling and disease.
    Huang ZP; Neppl RL; Wang DZ
    J Cardiovasc Transl Res; 2010 Jun; 3(3):212-8. PubMed ID: 20560042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNAs in heart failure: new targets in disease management.
    Elzenaar I; Pinto YM; van Oort RJ
    Clin Pharmacol Ther; 2013 Oct; 94(4):480-9. PubMed ID: 23852395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of human cardiac ion channel genes by microRNAs: theoretical perspective and pathophysiological implications.
    Luo X; Zhang H; Xiao J; Wang Z
    Cell Physiol Biochem; 2010; 25(6):571-86. PubMed ID: 20511702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of microRNAs in cardiac hypertrophy and heart failure.
    Wang N; Zhou Z; Liao X; Zhang T
    IUBMB Life; 2009 Jun; 61(6):566-71. PubMed ID: 19472179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Effects of MicroRNAs in the Development of Heart Failure.
    Guo YT; Xiao YC; Xu YL; Fan JF; Niu LY; Tan X; Wang YK
    Curr Cardiol Rep; 2023 Jul; 25(7):747-759. PubMed ID: 37233923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detailed characterization of microRNA changes in a canine heart failure model: Relationship to arrhythmogenic structural remodeling.
    Chen Y; Wakili R; Xiao J; Wu CT; Luo X; Clauss S; Dawson K; Qi X; Naud P; Shi YF; Tardif JC; Kääb S; Dobrev D; Nattel S
    J Mol Cell Cardiol; 2014 Dec; 77():113-24. PubMed ID: 25315712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNAs: new players in heart failure.
    Oliveira-Carvalho V; da Silva MM; Guimarães GV; Bacal F; Bocchi EA
    Mol Biol Rep; 2013 Mar; 40(3):2663-70. PubMed ID: 23242657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contrary microRNA Expression Pattern Between Fetal and Adult Cardiac Remodeling: Therapeutic Value for Heart Failure.
    Yan H; Li Y; Wang C; Zhang Y; Liu C; Zhou K; Hua Y
    Cardiovasc Toxicol; 2017 Jul; 17(3):267-276. PubMed ID: 27509882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNAs in Heart Failure, Cardiac Transplantation, and Myocardial Recovery: Biomarkers with Therapeutic Potential.
    Shah P; Bristow MR; Port JD
    Curr Heart Fail Rep; 2017 Dec; 14(6):454-464. PubMed ID: 28940102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNAs in heart failure: Non-coding regulators of metabolic function.
    Zhang X; Schulze PC
    Biochim Biophys Acta; 2016 Dec; 1862(12):2276-2287. PubMed ID: 27544699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update on the Pathogenic Implications and Clinical Potential of microRNAs in Cardiac Disease.
    Notari M; Pulecio J; Raya Á
    Biomed Res Int; 2015; 2015():105620. PubMed ID: 26221581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.